Australia's most trusted
source of pharma news
Friday, 8 August 2025
Friday, 8 August 2025
Subscribe
Login
Company job cuts reach 12,000
This Big Pharma has shed 12,000 global jobs in two years under a cost-cutting initiative with more jobs to go but there is good news for the ANZ team which is not expected to be impacted by further downsizing.
Workforce shrinks in tough call
Two companies detail global job cuts as part of their cost-saving strategies plus industry mourns the loss of two leaders
TODAY Your Week in Five Minutes
Medical Head notches a first
This company has appointed its first ever Head of Medical Affairs, nabbing a former Novartis exec for the job
8 March
Industry mourns executive death
Sydney-based Medical Director remembered for his unwavering commitment to his family and his service to the community
6 August
Bastas unveils billion-dollar deal
The push by Australia's largest generics manufacturer into innovative medicine just got a hefty bankroll
6 August
Pharma mourns company leader
Well-known figure in Australian pharma is being remembered as a champion for improving the lives of patients
6 August
Pharma to shed 6000 jobs
After announcing a 'multiyear optimisation initiative' last week, numbers firm up the workforce downsizing
5 August
Latest Jobs
Assistant Practice Manager | North ShoreHospital Specialist RepresentativePharmacy Account ManagerMedical AdministrationTraining ManagerTechnical LabourerQuality ManagerSenior Recruitment Consultant33 more...
Pharma in Focus Jobs
Marketing & Communications (3)
Sales & Customer Relations (15)
- Hospital Specialist Representative - Sydney
- Pharmacy Account Manager - Adelaide
- Hospital Sales Representative - Queensland
- Hospital Specialist Representative - Brisbane
- Key Account Manager - Sydney
- Accounts Receivable Officer - Nunawading
- Medical Devices Territory Manager - Brisbane
- Business Development Manager - Sydney
- Territory Manager - Animal Health - Cairns
- Territory Manager - Animal Health - Brisbane
- Inside Sales - Brisbane
- Territory Sales Manager - Auckland
- Territory Sales Manager - Auckland
- Customer Care Representative - Macquarie Park
- Customer Service Representative - Pemulwuy
Clinical & Medical, R&D (6)
- Medical Administration - Perth
- Medical Affairs Manager - East Ryde
- Clinical Research Associate III - Victoria
- Medical Devices Territory Manager - Brisbane
- Senior Clinical Research Scientist - Sydney
- Senior Medical Science Liaison - Melbourne
Regulatory, Pharmacovigilance & QA (6)
- Quality Manager - Ryde
- Senior Regulatory Affairs Associate - Sydney
- Quality & Regulatory Affairs Associate - Sydney
- Quality Assurance Associate - Gowanbrae
- Quality on the Floor Technician - Dallas
- Associate Director, Regulatory Affairs – APAC - Sydney
Devices (1)
Executive Roles (1)
Other (13)
- Assistant Practice Manager | North Shore - St Leonards
- Training Manager - Sydney
- Technical Labourer - New Lambton
- Senior Recruitment Consultant - Victoria
- Chief Operating Officer - Melbourne, VIC
- Digital Marketer - Sydney
- Financial Planning & Analysis Manager - New South Wales
- Senior Recruitment Consultant - Sydney
- Microbiology QC Analyst - Dallas
- Cloud Security Engineer - Sydney
- Multimedia Designer - Sydney
- Supply Chain and Logistics Specialist - Pymble
- Legal Counsel - Macquarie Park
Butler warns jobs under threat
Proposed US tariffs on pharmaceuticals has raised concerns for Australian jobs linked to more than $2B in exports
TODAY
Star AbbVie drug impresses... again
Rinvoq produces outstanding results in a phase 3 trial for a new indication, putting the competition on notice
TODAY
MAPA drops star speakers list
Sydney Summit tracking for a record turnout with two big names headlining the event plus a special global guest speaker
7 August
Manufacturing site name unveiled
New facility will add 7,000m2 over four floors to the Translational Research Institute's existing footprint
7 August
Seven drugs join TGA review list
Which innovative medicines including a pegged blockbuster and long-lost cancer treatment have hit the regulator's desk?
7 August
Pharma leadership in the hot seat
'Strong leadership' named as the top enabler to achieving strategic goals yet confidence in current leaders is less-than-ideal
7 August
Another funding path for Wegovy?
New studies have opened the door for brain disease indications for semaglutide, giving Novo another arrow in its funding quiver
7 August
Gilead 'glows' with grants program
Company's largest ever investment in Indigenous health aims to support the elimination of HIV and Hepatitis by 2030
6 August
Merck backs new test protocols
Company welcomes harmonised testing for diagnosis and treatment of endocrine disorders in children across ANZ
6 August
What's worrying Aussie pharma?
In an increasingly complex and cost-restrained work environment, these are industry's biggest concerns
5 August
J&J calls for '3rd Opinion'
Newly coined term designed to spark a social movement to elevate the patient voice and enhance shared decision-making
5 August
Access gap hits new record
Time between TGA approval and funding on the PBS is still increasing as the number of 'not yet listed' medicines soars
5 August
PBAC grappling with thorny issues
Three of the toughest questions facing the PBAC remain unresolved according to an update from the July meeting
5 August
Australia in Trump's strike zone
Pharmas have 60 days to lower the price of their drugs to mirror what they charge abroad, putting Australia in the firing line
4 August